Related Experiment Video
Updated: Jan 14, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Case Report: Late Hypersensitivity Reaction to Hydroxyurea in a Patient With Myeloproliferative Disorder
Navkirat Kahlon1, Sujatha Baddam2, Harinderjeet Kaur3
1Department of Medical Oncology, Mass General Cancer Center at Wentworth-Douglass Hospital, Dover, New Hampshire, USA.
Hydroxyurea, a key treatment for myelofibrosis, can cause rare hypersensitivity reactions. This case shows that discontinuing hydroxyurea and switching to ruxolitinib resolved symptoms, highlighting the need for careful management.
Area of Science:
- Hematology
- Pharmacology
Background:
- Hydroxyurea is a standard treatment for myeloproliferative neoplasms like myelofibrosis.
- Hypersensitivity reactions to hydroxyurea are rare but can necessitate treatment changes.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions